Menu
GeneBe

19-852329-A-G

Variant summary

Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong

The NM_001972.4(ELANE):c.1A>G(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

ELANE
NM_001972.4 start_lost

Scores

5
1
6

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 1.97
Variant links:
Genes affected
ELANE (HGNC:3309): (elastase, neutrophil expressed) Elastases form a subfamily of serine proteases that hydrolyze many proteins in addition to elastin. Humans have six elastase genes which encode structurally similar proteins. The encoded preproprotein is proteolytically processed to generate the active protease. Following activation, this protease hydrolyzes proteins within specialized neutrophil lysosomes, called azurophil granules, as well as proteins of the extracellular matrix. The enzyme may play a role in degenerative and inflammatory diseases through proteolysis of collagen-IV and elastin. This protein also degrades the outer membrane protein A (OmpA) of E. coli as well as the virulence factors of such bacteria as Shigella, Salmonella and Yersinia. Mutations in this gene are associated with cyclic neutropenia and severe congenital neutropenia (SCN). This gene is present in a gene cluster on chromosome 19. [provided by RefSeq, Jan 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 20 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PS1
Another start lost variant in NM_001972.4 (ELANE) was described as [Pathogenic] in ClinVar as 988327
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-852329-A-G is Pathogenic according to our data. Variant chr19-852329-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 1343367.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ELANENM_001972.4 linkuse as main transcriptc.1A>G p.Met1? start_lost 1/5 ENST00000263621.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ELANEENST00000263621.2 linkuse as main transcriptc.1A>G p.Met1? start_lost 1/51 NM_001972.4 P1
ELANEENST00000590230.5 linkuse as main transcriptc.1A>G p.Met1? start_lost 2/65 P1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cyclical neutropenia;C1859966:Neutropenia, severe congenital, 1, autosomal dominant Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeSep 09, 2021This sequence change affects the initiator methionine of the ELANE mRNA. The next in-frame methionine is located at codon 44. For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that disruption of the initiator codon affects ELANE function (PMID: 24184683). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. This variant is also known as 1287A>G I1-29A>G. Disruption of the initiator codon has been observed in individual(s) with severe congenital neutropenia (PMID: 14962902, 21618407, 23463630, 29076228). In at least one individual the variant was observed to be de novo. It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (ExAC no frequency). -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicNov 17, 2021PP1_moderate, PM2_supporting, PM4, PS2, PS4_moderate, PVS1_moderate -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.44
D
BayesDel_noAF
Pathogenic
0.40
Cadd
Benign
17
Dann
Benign
0.93
DEOGEN2
Benign
0.36
T;T
Eigen
Benign
-0.14
Eigen_PC
Benign
-0.24
FATHMM_MKL
Benign
0.40
N
M_CAP
Pathogenic
0.88
D
MetaRNN
Pathogenic
0.99
D;D
MetaSVM
Uncertain
0.31
D
MutationTaster
Benign
1.0
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.46
P;P
Vest4
0.94
MutPred
0.99
Gain of methylation at R5 (P = 0.0955);Gain of methylation at R5 (P = 0.0955);
MVP
0.99
ClinPred
0.64
D
GERP RS
2.1
Varity_R
0.95
gMVP
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr19-852329; API